Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Thrombosis and Thrombolysis

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11239-013-1000-2PMID 24097206
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Profibrinolytic microparticles are not adequately produced to compensate their prothrombotic effect

  2013cited by this paper
• Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis

  2012cited by this paper
• Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics

  2012cited by this paper
• Inflammatory mechanisms in obesity.

  2011cited by this paper
• Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.

  2011cited by this paper
• Effects of a high-protein, low-carbohydrate v. high-protein, moderate-carbohydrate weight-loss diet on antioxidant status, endothelial markers and plasma indices of the cardiometabolic profile

  2011cited by this paper
• Evaluation of Soluble P-Selectin as a Marker for the Diagnosis of Deep Venous Thrombosis

  2011cited by this paper
• John Conrad Waterlow CMG, FRS, FRCP, DSc

  2011cited by this paper
• Analysis of tissue factor positive microparticles.

  2010cited by this paper
• Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism.

  2010cited by this paper
• A multicolor flow cytometric assay for measurement of platelet-derived microparticles.

  2010cited by this paper
• Circulating endothelial microparticles as a marker of cerebrovascular disease

  2009cited by this paper
• Healthy obesity

  2009cited by this paper
• Endothelial microparticles: a universal marker of vascular health?

  2009cited by this paper
• Leukocyte – endothelial interactions in inflammation

  2009cited by this paper
• Platelet-derived microparticles and coagulation activation in breast cancer patients

  2008cited by this paper
• Flow cytometric measurement of microparticles: Pitfalls and protocol modifications

  2008cited by this paper
• Platelet microparticles and vascular cells interactions: A checkpoint between the haemostatic and thrombotic responses

  2008cited by this paper
• Microparticle-associated P-selectin reflects platelet activation in preeclampsia

  2007cited by this paper
• Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity.

  2007cited by this paper
• Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease.

  2006cited by this paper
• Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease.

  2006cited by this paper
• Circulating procoagulant microparticles in obesity.

  2006cited by this paper
• Elevation of circulating endothelial microparticles in patients with chronic renal failure

  2006cited by this paper
• P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.

  2006cited by this paper
• Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome.

  2006cited by this paper
• Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects

  2006cited by this paper
• Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure.

  2005cited by this paper
• [Microparticles and cardiovascular disease].

  2005cited by this paper
• Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels

  2005influential reference
• Platelets in inflammation and atherogenesis.

  2005cited by this paper
• Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation

  2005cited by this paper
• Measuring circulating cell‐derived microparticles

  2004cited by this paper
• Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis.

  2004cited by this paper
• Tissue factor: A key molecule in hemostatic and nonhemostatic systems

  2004cited by this paper
• Thrombin formation.

  2003cited by this paper
• Microparticles in cardiovascular diseases.

  2003cited by this paper
• The adhesion molecule P-selectin and cardiovascular disease.

  2003cited by this paper
• Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation.

  2002cited by this paper
• Type 1 and type 2 diabetic patients display different patterns of cellular microparticles.

  2002cited by this paper
• Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus

  2002cited by this paper
• Obesity prevention: the case for action

  2002cited by this paper
• Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus

  2002cited by this paper
• Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

  2000cited by this paper
• Association of Fibrinogen With Cardiovascular Risk Factors and Cardiovascular Disease in the Framingham Offspring Population

  2000cited by this paper
• Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule.

  1999cited by this paper
• Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules

  1999cited by this paper
• Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

  1999cited by this paper
• Platelet/Polymorphonuclear Leukocyte Interaction: P-Selectin Triggers Protein-Tyrosine Phosphorylation–Dependent CD11b/CD18 Adhesion: Role of PSGL-1 as a Signaling Molecule

  1999cited by this paper
• American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee.

  1998cited by this paper
• Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

  1998cited by this paper
• American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease

  1998cited by this paper

• Functional Foods in Preventing Human Blood Platelet Hyperactivity-Mediated Diseases—An Updated Review

  2024cites this paper
• Low-Grade Activation of the Extrinsic Coagulation Pathway in Patients with Ulcerative Colitis

  2024cites this paper
• A Review of MicroRNAs and lncRNAs in Atherosclerosis as Well as Some Major Inflammatory Conditions Affecting Atherosclerosis

  2024cites this paper
• New signaling kid on the block in the endocrine system: the role of extracellular vesicles.

  2023cites this paper
• Pravastatin reduces plasma levels of extracellular vesicles in pregnancies at high risk of term preeclampsia

  2023cites this paper
• Periodontitis & preeclampsia: were outer membrane vesicles a potential connection?

  2023cites this paper
• OxLDL sensitizes platelets for increased formation of extracellular vesicles capable of finetuning macrophage gene expression.

  2023cites this paper
• An insight of naturally occurring phytoconstituents and novel approaches towards the treatment of diabetes.

  2023cites this paper
• Effects of bariatric surgery on blood and vascular large extracellular vesicles according to type 2 diabetes status.

  2023cites this paper
• The Role of Microparticles in Polycystic Ovarian Syndrome. An Updated Review

  2022cites this paper
• Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches

  2022cites this paper
• The role of platelet microvesicles in the pathogenesis of preeclampsia

  2022cites this paper
• Utility of Platelet Derived Microparticles in Predicting Complications of Diabetes Mellitus

  2022cites this paper
• Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease

  2021cites this paper
• Platelet hyperactivity in COVID-19: Can the tomato extract Fruitflow® be used as an antiplatelet regime?

  2021cites this paper
• Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting

  2021cites this paper
• Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart’s Vulnerability to Ischemia-Reperfusion Injury

  2021cites this paper
• Protective Role of Platelets in Myocardial Infarction and Ischemia/Reperfusion Injury

  2021cites this paper
• Dietary Antiplatelets: A New Perspective on the Health Benefits of the Water-Soluble Tomato Concentrate Fruitflow®

  2021cites this paper
• The Mechanisms of the Development of Atherosclerosis in Prediabetes

  2021cites this paper
• PAR-4/Ca2+-calpain pathway activation stimulates platelet-derived microparticles in hyperglycemic type 2 diabetes

  2021cites this paper
• Overview of extracellular vesicles in the pathogenesis of preeclampsia†

  2021cites this paper
• Extracellular Vesicles in Comorbidities Associated with Ischaemic Heart Disease: Focus on Sex, an Overlooked Factor

  2021influential citation
• Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2020cites this paper
• Avoiding cardiovascular disease in type1and type2 Diabetes Mellitus by targeting the coagulatory Alterations A Systematic Review

  2020cites this paper
• Interplay between Endoplasmic Reticulum Stress and Large Extracellular Vesicles (Microparticles) in Endothelial Cell Dysfunction

  2020cites this paper
• Diabetes and Hyperglycemia Affect Platelet GPIIIa Expression: Effects on Adhesion Potential of Blood Platelets from Diabetic Patients under In Vitro Flow Conditions

  2020cites this paper
• Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention

  2020cites this paper
• Receptor GP IIb/IIIa as an Indicator of Risk in Vascular Events

  2019cites this paper
• Impaired signalling pathways mediated by extracellular vesicles in diabesity.

  2019cites this paper
• Molecular Mechanisms Underpinning Microparticle-Mediated Cellular Injury in Cardiovascular Complications Associated with Diabetes

  2019influential citation
• The role of acetylsalicylic acid and circulating microRNAs in primary prevention of cardiovascular events in patients with Diabetes Mellitus Type 2 - A Review.

  2019cites this paper
• Platelet-Derived Extracellular Vesicles

  2019cites this paper
• Lipid Metabolism and Signaling in Platelet Function.

  2019cites this paper
• Liquid Biopsies: Microvesicles in Cardiovascular Disease

  2019cites this paper
• Role ofpreconception endothelial dysfunction in development of obstetric complications

  2019cites this paper
• Polyphenols: Modulators of Platelet Function and Platelet Microparticle Generation?

  2019cites this paper
• Coagulatory Defects in Type-1 and Type-2 Diabetes

  2019cites this paper
• Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes

  2019cites this paper
• ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETES. Review

  2019cites this paper
• Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

  2019cites this paper
• DMSO_A_225761 2819..2828

  2019cites this paper
• sFlt-1/PLGF

  2018cites this paper
• Circulating Microparticles and Coagulation Profiles in Patients with Advanced Stage Solid Tumors

  2018cites this paper
• Platelet activity and hypercoagulation in type 2 diabetes

  2018cites this paper
• Platelet Microparticles Mediate Glomerular Endothelial Injury in Early Diabetic Nephropathy.

  2018cites this paper
• Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies

  2018cites this paper
• THE ROLE OF INTERACTIONS BETWEEN TROPHOBLAST- DERIVED EXTRACELLULAR MICROVESICLES, IMMUNE CELLS AND ENDOTHELIUM IN PATHOGENESIS OF PRE-ECLAMPSIA

  2018cites this paper
• CIRCULATING MICROPARTICLES AND HYPERCOAGULABILITY IN OBESITY

  2018cites this paper
• Circulating microparticles levels are increased in patients with diabetic kidney disease: A case-control research.

  2018cites this paper
• Emerging Concepts of Megakaryocytes Distribution and Role in Inflammatory Joint Disease

  2018cites this paper
• A Combination of Proteomic Approaches Identifies A Panel of Circulating Extracellular Vesicle Proteins Related to the Risk of Suffering Cardiovascular Disease in Obese Patients

  2018cites this paper
• Extracellular vesicles compartment in liquid biopsies: Clinical application.

  2017cites this paper
• Monocyte-Derived Procoagulant Microvesicles Induced by High Glucose Can Be Attenuated by the Antioxidant N-Acetyl-L-Cysteine, Partly Through the P38/MAPK Pathway

  2017cites this paper
• Extracellular vesicles in obesity and diabetes mellitus.

  2017cites this paper
• Mechanisms of Platelet Activation in Diabetes Mellitus

  2017cites this paper
• Microparticles during long-term follow-up after acute myocardial infarction

  2017cites this paper
• Platelets and Platelet-Derived Microvesicles as Immune Effectors in Type 2 Diabetes.

  2017cites this paper
• Platelet extracellular vesicles as biomarkers for arterial thrombosis

  2017cites this paper
• Pathogenic roles of microvesicles in diabetic retinopathy

  2017cites this paper
• The function of microparticles and the research progress of diabetes and microparticles

  2017cites this paper
• Platelet-Enriched MicroRNAs and Cardiovascular Homeostasis

  2017cites this paper
• An exploration of the relationship between cardiovascular health, lifestyle factors and platelet function.

  2017cites this paper
• Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis

  2016cites this paper
• Cell-Derived Microparticles in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta-Analysis

  2016cites this paper
• Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients.

  2016cites this paper
• The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis

  2016cites this paper
• Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes.

  2016cites this paper
• Microparticle levels after arterial injury and NO therapy in diabetes.

  2016cites this paper
• Preeclampsia and Extracellular Vesicles

  2016cites this paper
• The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking

  2016cites this paper
• El ácido acetilsalicílico reduce la liberación de micropartículas eritrocitarias, monocitarias y de células del músculo liso vascular en pacientes diabéticos

  2016cites this paper
• Microparticles as new markers of cardiovascular risk in diabetes and beyond

  2016influential citation
• Original Article Proteomic characteristics of circulating microparticles in patients with newly-diagnosed type 2 diabetes

  2016cites this paper
• Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.

  2015cites this paper
• Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells.

  2015cites this paper
• Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders.

  2015cites this paper
• The Immune Phenotypes of Circulating Microparticles in Patients with Diabetes Mellitus: Relevance to Serum Galectin-3 Level

  2015cites this paper
• Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes.

  2014cites this paper
• Activated Platelets from Diabetic Rats Cause Endothelial Dysfunction by Decreasing Akt/Endothelial NO Synthase Signaling Pathway

  2014cites this paper
• Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events

  2014cites this paper
• Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases.

  2014cites this paper
• Emerging roles for platelets as immune and inflammatory cells.

  2014cites this paper